Unique Ingredient Identifier 06XEA2VD56 is listed as a ingredient substance
| RN | 1338-43-8 |
| EC | 215-665-4 |
| NCIT | C75654 |
| RXCUI | 1363056 |
| PUBCHEM | 9920342 |
| INN ID | 1875 |
| MF | C24H44O6 |
| INCHI KEY | NWGKJDSIEKMTRX-AAZCQSIUSA-N |
| SMILES | CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O |
UNII 06XEA2VD56 SORBITAN MONOOLEATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ORAL | CAPSULE | 40 MG |
| ORAL | CAPSULE, SOFT GELATIN | 153.9 MG |
| ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | 10 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 1.7 MG |
| ORAL | EMULSION | NA |
| ORAL | SOLUTION | 150 MG/1ML |
| ORAL | SUSPENSION | NA |
| ORAL | TABLET | 1.7 MG |
| ORAL | TABLET, COATED | 0.13 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 1.89 MG |
| ORAL | TABLET, FILM COATED | 0.69 MG |
| ORAL | TABLET, SUSTAINED ACTION | 7.8 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 1 MG |
| RECTAL | SUPPOSITORY | 22 MG |
| TOPICAL | CREAM | 0.4 %W/W |
| TOPICAL | CREAM, AUGMENTED | 0.2 %W/V |
| TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 3.5 %W/W |
| TOPICAL | EMULSION | 2.5 %W/W |
| TOPICAL | EMULSION, CREAM | 3.5 %W/W |
| TOPICAL | GEL | 0.2 %W/W |
| TOPICAL | LOTION | 7 %W/W |
| TOPICAL | OINTMENT | NA |
| TOPICAL | SPRAY | 0.25 %W/W |
| TRANSDERMAL | FILM, CONTROLLED RELEASE | NA |